T. Rowe Price GNMA Fund, Inc. has filed its latest financial report, showcasing a total asset value of approximately $413 million and net assets of around $333 million. This filing is significant as it underscores the fund's ongoing stability and performance in the competitive investment landscape, particularly within mortgage-backed securities.
The report, filed on October 28, 2026, as an NPORT-P form, provides insights into the fund's financial health as of August 31, 2026. It reveals total liabilities of approximately $80 million, indicating a solid net asset position. The fund's management continues to focus on maintaining a robust portfolio, which is essential for attracting and retaining investors.
Background
T. Rowe Price GNMA Fund, Inc. is an investment fund incorporated in Maryland, specializing in government-backed mortgage securities. The fund is part of the broader investment management industry, which is characterized by its focus on various asset classes, including stocks, bonds, and real estate. The fund operates under the SEC Act of 1940, with a fiscal year ending on May 31. The fund's CIK is 0000779785, and it has consistently filed various forms to keep investors informed about its financial status.
What the Filing Says
The recent filing indicates that the fund's total assets amount to $412,976,774, with net assets reported at $332,603,977. The filing notes, "The filing does not say what happens next." This lack of forward-looking guidance may leave investors seeking more information on future strategies or changes in management.
Impact
This update may affect current and potential investors in the T. Rowe Price GNMA Fund, as it highlights the fund's financial stability and asset management capabilities. The filing also serves as a benchmark for competing investment funds within the mortgage-backed securities sector, as they assess their performance against T. Rowe Price.
What's Next
The filing does not say what happens next. Investors will likely await further disclosures or updates regarding the fund's investment strategies or changes in asset allocation in subsequent filings.
Read Next
BNY Mellon Funds Trust Files Annual Report, Showcases Growth
Listed Funds Trust Delays Metals.io Uranium ETF Launch
Equinox Partners Increases Stake in Silvercrest Asset Management
Nexa Resources reports strong Q3 2026 financial results
TFI International reports Q3 2026 financial results
Bambusa Therapeutics grants stock options to director Liang Howard










